List of Excipients in API TIAGABINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TIAGABINE HYDROCHLORIDE
Excipients in ANDA-approved (generic) drugs containing TIAGABINE HYDROCHLORIDE
Detailed excipient profiles for TIAGABINE HYDROCHLORIDE
Excipient focus: ANHYDROUS LACTOSE
TIAGABINE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
TIAGABINE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
TIAGABINE HYDROCHLORIDE drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| Carilion Materials Management | tiagabine hydrochloride | 68151-4235 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | tiagabine hydrochloride | 16714-154 |
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| Novadoz Pharmaceuticals LLC | tiagabine hydrochloride | 72205-087 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
TIAGABINE HYDROCHLORIDE drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | tiagabine hydrochloride | 16714-154 |
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| Novadoz Pharmaceuticals LLC | tiagabine hydrochloride | 72205-087 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| Carilion Materials Management | tiagabine hydrochloride | 68151-4235 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TIAGABINE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
TIAGABINE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
TIAGABINE HYDROCHLORIDE drug variants containing CROSPOVIDONE
TIAGABINE HYDROCHLORIDE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
TIAGABINE HYDROCHLORIDE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| Carilion Materials Management | tiagabine hydrochloride | 68151-4235 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
TIAGABINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
TIAGABINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | tiagabine hydrochloride | 16714-154 |
| Novadoz Pharmaceuticals LLC | tiagabine hydrochloride | 72205-087 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
TIAGABINE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| Northstar Rx LLC | tiagabine hydrochloride | 16714-154 |
| Carilion Materials Management | tiagabine hydrochloride | 68151-4235 |
| Novadoz Pharmaceuticals LLC | tiagabine hydrochloride | 72205-087 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED COTTONSEED OIL
TIAGABINE HYDROCHLORIDE drug variants containing HYDROGENATED COTTONSEED OIL
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | tiagabine hydrochloride | 16714-154 |
| Novadoz Pharmaceuticals LLC | tiagabine hydrochloride | 72205-087 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing HYDROGENATED COTTONSEED OIL
Excipient focus: HYDROGENATED SOYBEAN OIL
TIAGABINE HYDROCHLORIDE drug variants containing HYDROGENATED SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| Carilion Materials Management | tiagabine hydrochloride | 68151-4235 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing HYDROGENATED SOYBEAN OIL
Excipient focus: HYDROXYPROPYL CELLULOSE
TIAGABINE HYDROCHLORIDE drug variants containing HYDROXYPROPYL CELLULOSE
TIAGABINE HYDROCHLORIDE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
TIAGABINE HYDROCHLORIDE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
TIAGABINE HYDROCHLORIDE drug variants containing HYPROMELLOSES
TIAGABINE HYDROCHLORIDE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tiagabine hydrochloride | 0093-5030 |
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| Cephalon LLC | tiagabine hydrochloride | 63459-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
TIAGABINE HYDROCHLORIDE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | tiagabine hydrochloride | 16590-832 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing LACTOSE
Excipient focus: MAGNESIUM STEARATE
TIAGABINE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
TIAGABINE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
TIAGABINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 6000
TIAGABINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYSORBATE 80
TIAGABINE HYDROCHLORIDE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: PROPYL GALLATE
TIAGABINE HYDROCHLORIDE drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | tiagabine hydrochloride | 52536-350 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing PROPYL GALLATE
Excipient focus: SILICON DIOXIDE
TIAGABINE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
TIAGABINE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
TIAGABINE HYDROCHLORIDE drug variants containing STARCH, CORN
TIAGABINE HYDROCHLORIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
TIAGABINE HYDROCHLORIDE drug variants containing STEARIC ACID
TIAGABINE HYDROCHLORIDE drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
TIAGABINE HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tiagabine hydrochloride | 62756-200 |
| >Company | >Ingredient | >NDC |
TIAGABINE HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
TIAGABINE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
TIAGABINE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links